发布时间: 2025 - 11 - 28
In November, Core Medical's STAR Market IPO application was accepted, making it the first innovative medical device company to be accepted since the resumption of the STAR Market's fifth-set listing standards. With this, Efung Capital has become the only institution since the resumption of the STAR Market's fifth-set standards to simultaneously have a presence spanning the first company to pass review and list (Orygen Biotech), the second company to pass review (Beixin Life), the first company to be accepted (Trinomab), and the first innovative medical device company to be accepted...
浏览次数:7
发布时间: 2025 - 11 - 27
On November 27, 2025, Xunlu Bio announced that its independently developed fully human BCMA-targeted CAR-T cell therapy product Fucaso® (Equecabtagene Autoleucel) has received approval from the Hong Kong Department of Health for the treatment of adult patients with relapsed or refractory multiple myeloma (R/R MM) who have progressed after at least three prior lines of therapy.This marks Fucaso® as the first China-developed CAR-T cell therapy product approved in Hong Kong, and also the first domestically produced ATMP (Advanced Therapy Medicinal Product) to receive international PIC/S...
浏览次数:8
发布时间: 2025 - 11 - 24
Recently, Jingwei Shida Medical Technology Co., Ltd. ("Jingwei Shida") announced the completion of a new financing round exceeding RMB 100 million, co-led by Efung Zhuohua Fund, Huabin Fengtai Private Equity Fund, and Changfei Industrial Fund. The funds will be primarily used for continued R&D, scaled production, clinical application promotion, and global commercialization of confocal microscopy endoscopy products.As a high-end medical device enterprise focused on precision diagnosis and treatment of early-stage tumors, Jingwei Shida has remained committed to its vision and missi...
浏览次数:4
发布时间: 2025 - 11 - 19
On November 18, the 20th China Economic Forum, hosted by China Economic Weekly magazine under People's Daily, was successfully held at the Guangzhou Nansha International Convention Center.The China Economic Forum is a major economic forum event hosted by China Economic Weekly magazine under People's Daily. Since its inception in 2001, it has had a broad influence across government, business, and academic circles.It is reported that the theme of this year's forum is "Chinese Modernization and the Outlook for China's Economy in the 15th Five-Year Plan.&qu...
浏览次数:5
114页次18/29首页PREV...  13141516171819202122...NEXTlast page
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务